Global Fusion Biopsy Market Size, Trends & Analysis - Forecasts to 2026

Actionable Insights In Global Fusion Biopsy Market

According to Global Market Estimates, the fusion biopsy market will grow from 2020 to 2026 with a CAGR value of 10.5%. The market will grow exponentially mainly due to increasing cancer cases, rising awareness and practice of the use of fusion biopsy system for oncology screening procedures, rising preference for avoiding a repeat biopsy during cancer treatment, increasing priority for a highly accurate and sensitive screening tool for prostate cancer, and increasing government support for the insurance coverage of fusion biopsy-based treatment.

 

By Component (Fully Integrated Biopsy System, Related Software and Post Sale Service), By Route of Biopsy (Transrectal Route and Transperineal Route), By End User (Hospitals & Cancer Centers, Diagnostic & Imaging Labs, Outpatient Surgery Centers, and Academic & Research Institutes), By Region (Asia Pacific, MEA, CSA, North America, and Europe), Company Market Share & Competitor Analysis

 

Browse 119 Market Data Tables and 77 Figures spread through 140 Pages on "Global Fusion Biopsy Market - Forecasts to 2026" https://www.globalmarketestimates.com/market-report/global-fusion-biopsy-market-2257

 

Key Market Insights:

·         The fusion biopsy market is ought to grow from 2020 to 2026 with a 10.5% CAGR value.

·         The full integrated biopsy system will be the largest shareholder in the market and will contribute the highest to the total revenue of the business.

·         The Transrectal route being the gold standard method for cancer detection will have the largest share in this market

·         The hospital and cancer center will be the fastest and largest shareholder of the market as per the end-user segments is concerned.

·         The Asia Pacific will grow faster than CSA, MEA, and Europe, while North America will be the leader of the market during 2020-2026.

Major companies offering such innovative fusion biopsy systems are  KOELIS, Medical Targeting Technologies GmbH, Koninklijke Philips N.V., BK Medical Holding Company, Inc., MedCom, innoMedicus Ltd., Siemens Healthineers, UltraMed Pty Ltd, ESAOTE SPA, Hitachi, Ltd., BioBot Surgical, Focal Healthcare, and UC-Care Medical Systems Ltd.

 

Browse the Global Fusion Biopsy Market Report @: https://www.globalmarketestimates.com/market-report/global-fusion-biopsy-market-2257

 

·         Component Outlook (Revenue, USD Million, 2020 - 2026)

Ø  Fully Integrated Biopsy System

Ø  Related Software

Ø  Post Sale Service

·         Route of Biopsy Outlook (Revenue, USD Million, 2020 - 2026)

Ø  Transrectal Route

Ø  Transperineal Route

 

·         End-User Outlook (Revenue, USD Million, 2020 - 2026)

Ø  Hospitals & Cancer Centers

Ø  Diagnostic & Imaging Labs

Ø  Outpatient Surgery Centers

Ø  Academic & Research Institutes

 

·         Regional Outlook (Revenue, USD Million, 2020 - 2026)

Ø  North America

o   U.S.

o   Canada

o   Mexico

Ø  Europe

o   Germany

o   UK

o   France

o   Spain

o   Italy

o   Rest of Europe

Ø  Asia Pacific

o   China

o   India

o   Japan

o   South Korea

o   Australia

o   Rest of APAC

Ø  Central & South America

o   Brazil

o   Argentina

o   Chile

o   Rest of CSA

Ø  Middle East & Africa

o   Saudi Arabia

o   South Africa

o   UAE

o   Rest of MEA

 

Contact: Yash Jain

Email address: sales@globalmarketestimates.com

Phone Number: +16026667238

Website: https://www.globalmarketestimates.com/

Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php